Articles by Andrew Carr

1 2 3 4 5

Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy

Siefried, Krista J.; Mao, Limin; Cysique, Lucette A.; More

AIDS. 32(1):35-48, January 2, 2018.

Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment

Stellbrink, Hans-Jürgen; Le Fevre, Eric; Carr, Andrew; More

AIDS. 30(8):1229-1238, May 15th, 2016.

Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial

Martin, Allison; Amin, Janaki; Cooper, David A; More

AIDS. 24(17):2657-2663, November 13th, 2010.

The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters

Martinez, Esteban; Visnegarwala, Fehmida; Grund, Birgit; More

AIDS. 24(3):353-563, January 28th, 2010.

HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial

Calmy, Alexandra; Gayet-Ageron, Angèle; Montecucco, Fabrizio; More

AIDS. 23(8):929-939, May 15th, 2009.

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection

Wand, Handan; Calmy, Alexandra; Carey, Dianne L; More

AIDS. 21(18):2445-2453, November 30th, 2007.

Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men—a randomized, placebo-controlled study

Mallon, Patrick WG; Miller, John; Kovacic, Jason C; More

AIDS. 20(7):1003-1010, April 24th, 2006.

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

Martin, Allison; Smith, Don E; Carr, Andrew; More

AIDS. 18(7):1029-1036, April 30th, 2004.

A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1...

Carr, Andrew; Chuah, John; Hudson, Jeff; More

AIDS. 14(9):1171-1180, June 16th, 2000.

Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals

Kaufmann, Gilbert R.; Duncombe, Chris; Cunningham, Philip; More

AIDS. 12(13):1625-1630, September 10th, 1998.

Increased frequency of CCR-5 Δ32 heterozygotes among long-term non-progressors with HIV-1 infection

Stewart, Graeme J.; Ashton, Lesley J.; Biti, Robyn A.; More

AIDS. 11(15):1833-1838, December 11th, 1997.

1 2 3 4 5